Upgrade to SI Premium - Free Trial

Pre-Open Stock Movers 01/06: (CNAT) (CCXI) (MBLY) Higher; (CMG) (VRX) (AAPL) Lower (more...)

January 6, 2016 9:28 AM
Conatus Pharmaceuticals (NASDAQ: CNAT) 24.6% HIGHER; three-month, double-blind, placebo-controlled stage of the company’s multicenter Phase 2 Liver Cirrhosis clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles